Wound Care Biologics Market
- 2026 年市場規模
- USD 2.3 Bn
- 2033 年預估規模
- USD 3.7 Bn
- 年複合成長率 CAGR
- 7.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Wound Care Biologics Market, By Product Type (Skin Substitute (Biological, Allografts, Xenografts, Others), Synthetic (Topical Agents)), By Wound Type (Chronic Wounds (Diabetic Foot Ulcers (DFU), Venous Leg Ulcers, Others), Acute Wounds (Burns, Surgical & Traumatic Wounds, Others)), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products include tissue-engineered products, which are designed to either temporarily or permanently replace the altered skin. Skin substitutes are commonly used products for wound management and have application for treating various ailments such as pressure ulcers, diabetic neuropathic ulcers, and vascular insufficiency ulcers.
Market Dynamics
Increasing incidences of chronic ulcers, owing to rising prevalence of diabetes, increasing surgical procedures, and rise in trauma cases are major driving factors for growth of wound care biologics market. According to the survey by World Health Organization, 2014, injuries resulting from traffic collisions, drowning, poisoning, falls or burns account for 9% of the global mortality. Also, according to a study by BMJ Journal Injury Prevention, 2013, an estimated 973 million people sustained injuries that warranted some type of healthcare and 4.8 million people died from injuries. The Journal also stated that major injury causes included road injury (29.1%), self-harm (17.6%), falls (11.6%), and interpersonal violence (8.5%). Manufacturers are also focused on extensive research and development to develop new products and expand their product portfolio. For instance, in 2016, Integra LifeSciences Holdings Corporation received FDA approval for Integra Dermal Regeneration Template (IDRT) for the treatment of diabetic foot ulcers that is marketed under the name of Integra Omnigraft Dermal Regeneration Matrix. Moreover, public awareness for biologics has positively contributed to the market growth, as people are opting for enhanced medical care for preventing wounds to minimize the morbidity associated with the formation of chronic wounds. However, higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.
Key features of the study
• This report provides in-depth analysis of wound care biologics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global wound care biologics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global wound care biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the wound care biologics market
Market Segmentation
• By Product Type (Revenue, USD Bn, 2021-2033)
o Skin Substitute
Biological
Allografts
Xenografts
Others
o Synthetic
Topical Agents
• By Wound Type (Revenue, USD Bn, 2021-2033)
o Chronic Wounds
Diabetic Foot Ulcers (DFU)
Venous Leg Ulcers
Others
o Acute Wounds
Burns
Surgical & Traumatic Wounds
Others
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Clinics
o Ambulatory Surgical Centers
o Home Care Settings
o Others
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Competitive Landscape
o Smith & Nephew Plc.
o Organogenesis, Inc.
o Integra Lifesciences Holdings Corporation
o Skye Biologics
o Alphatec Holdings, Inc.
o Solsys Medical LLC
o Amino Technology LLC
o Osiris Therapeutics, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Wound Type
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
Industry Trends
o Technological Advancements
o Regulatory Scenario
o Reimbursement Scenario
o Key Highlights
o PEST Analysis
o Epidemiology
o Impact Analysis
4. Global Wound Care Biologics Market, By Product Type, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Skin Substitute
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Biological
o Allografts
o Xenografts
o Others
o Synthetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Topical Agents
5. Global Wound Care Biologics Market, By Wound Type, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Chronic Wounds
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Segment Trends
o Diabetic Foot Ulcers (DFU)
o Venous Leg Ulcers
o Others
o Acute Wounds
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Segment Trends
o Burns
o Surgical & Traumatic Wounds
o Others
6. Global Wound Care Biologics Market, By End User, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Segment Trends
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
7. Global Wound Care Biologics Market, By Region, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
o North America
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By Wound Type, 2021–2033, (US$ Billion)
Market Size and Forecast, By End User, 2021–2033, (US$ Billion)
Market Size and Forecast, By Country, 2021–2033, (US$ Billion)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
Smith & Nephew Plc
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Organogenesis, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Integra Lifesciences Holdings Corporation
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Skye Biologics
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Alphatec Holdings, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Solsys Medical LLC
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Amino Technology LLC
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
Osiris Therapeutics, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
Browse 38 market data tables and 26 figures on Wound Care Biologics Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們